Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17708
Country/Region: South Sudan
Year: 2016
Main Partner: IntraHealth International, Inc.
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,309,639 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $47,363
Health Systems Strengthening (OHSS) $31,899
Testing: HIV Testing and Counseling (HVCT) $469,939
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $129,771
Treatment: Adult Treatment (HTXS) $611,170
Treatment: Pediatric Treatment (PDTX) $19,497
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 319
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 377
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 19,952
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 8,155
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 28,803
HTS_TST Service Delivery Point (Facility): Index testing 2017 780
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,890
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 733
HTS_TST Service Delivery Point (Facility): Other PITC 2017 2,240
HTS_TST Service Delivery Point (Facility): Outpatient 2017 2,859
HTS_TST Service Delivery Point (Facility): Pediatric 2017 663
HTS_TST Service Delivery Point (Facility): PMTCT 2017 9,570
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 862
HTS_TST Service Delivery Point (Facility): VCT 2017 9,206
HTS_TST Sum of Aggregated Age/Sex <15 2017 696
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 28,107
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 28,803
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 84
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 85
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 861
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 703
PMTCT_ART New on ART 2017 493
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,570
PMTCT_STAT By: Known positives at entry 2017 98
PMTCT_STAT By: Number of new positives identified 2017 268
PMTCT_STAT Number of new ANC and L&D clients 2017 11,050
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,570
PMTCT_STAT Sum of Positives Status disaggregates 2017 366
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 12
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 10
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 30
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 30
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 123
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 223
TB_SCREENDX Screen Result: Screened Positive for TB 2017 123
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 1,391
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,637
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 58
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 70
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,156
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 20
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 115
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 26
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 136
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 297
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 297
TX_CURR Aggregated Age/Sex: <15 Female 2017 89
TX_CURR Aggregated Age/Sex: <15 Male 2017 116
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,959
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,782
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 4,946
TX_CURR Sum of Aggregated Age/Sex <15 2017 205
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 4,741
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 4,946
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 61
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 78
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,045
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 569
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,956
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,753
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 28
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 293
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 286
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 628
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 897
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 40
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 30
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 425
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 402